Collegium Pharma Stock Price (NASDAQ:COLL)

Add to My Stocks
$14.87 $0.1 (0.67%) COLL stock closing price Feb 17, 2017 (Closing)
Prev Close* : $14.97
Market Cap:
Day Low: $14.66
52 Week Low: $8.24
Open: $14.93
Volume: 283318
Day High: $15.07
52 Week High: $21.45

Latest Stock Market News

Latest Articles

Collegium Pharma News - From Partners

Collegium Announces the Launch of OpioidIQ   by Globe Newswire on Sep 06, 2016

COLL Stockcharts

View COLL PE ratio, PS ratio stocks charts and compare with peers.
COLL Chart
Note: Compare Collegium Pharma stock price history with the index and industry peers.

COLL Industry Peers

Company Price Change (%)
Ptc Therapeutics (PTCT)14.160.38 (2.76%)
Biocryst Pharma (BCRX)6.560.02 (0.3%)
Kempharma (KMPH)3.60.1 (2.86%)
Pain Therapeutics (PTIE)0.60.01 (1.69%)
Egalet (EGLT)5.030.03 (0.6%)
Acura Pharma (ACUR)0.860.03 (3.37%)
Nektar Therapeutics (NKTR)13.10.12 (0.92%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Esperion Therapeutics (ESPR)251.81 (7.81%)
Cempra (CEMP)3.350.18 (5.67%)
Portola Pharma (PTLA)31.681.41 (4.66%)
Tesaro Inc (TSRO)190.367.8 (4.27%)
Genocea Biosciences (GNCA)4.60.16 (3.6%)
Achaogen (AKAO)22.680.68 (3.09%)
ChemoCentryx (CCXI)7.040.21 (3.07%)
Top gainers from Medical-Drugs industry
* As of Feb 18, 2017
CompanyPriceChange (%)
ArQule (ARQL)1.20.27 (18.37%)
Infinity Pharma (INFI)2.440.13 (5.06%)
ImmunoGen (IMGN)2.430.07 (2.8%)
Lannett Co (LCI)22.40.6 (2.61%)
Zogenix (ZGNX)10.20.25 (2.39%)
La Jolla Pharma (LJPC)18.970.46 (2.37%)
Depomed (DEPO)16.470.38 (2.26%)
Top losers from Medical-Drugs industry
* As of Feb 18, 2017

Collegium Pharma Financial Statements

income statement201520142013
Net Sales Or Revenues---
Net Income-27.25M-17.91M-16.19M
Total Operating Expense26.9M17.65M16.03M
view Collegium Pharmaceutical Inc income statement
balance sheet201520142013
Total Assets97.71M5.09M9.03M
Total Liabilities12.64M17.33M3.45M
Shareholders Equity85.07M-12.24M5.58M
view Collegium Pharmaceutical Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities3.33M-0.21M-0.63M
Net Cash From (Used By) Operating Activities-21.56M-17.94M-16.53M
Increase (Decrease) In Prop Plant And Equipment-0.36M-0.01M-0.2M
view Collegium Pharmaceutical Inc cashflow statement

Collegium Pharmaceutical Inc Stock News - Partner Headlines

Collegium Pharma Stock Message Board

An investor needs to spend 14.87 to buy COLL stock, as the closing Collegium Pharma stock price is 14.87. Looking at Collegium Pharma market capitalization, which currently stands at 428.31M, we can say that COLL stock is a Small cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Collegium Pharma stock analysis.

The terms stocks and shares mean the same thing. For Ex: Collegium Pharma stock price and Collegium Pharma share price mean the same thing. The volume of shares traded stood at 283318 on the last trading day, as is evident from Collegium Pharma stock chart, and COLL stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Collegium Pharma stock price history.